Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Ed Rozynski

This article was originally published in The Gray Sheet

Executive Summary

AdvaMed executive VP-global strategy & analysis departs trade association to launch Washington, D.C.-based international policy and political advocacy firm Rozynski & Associates. AdvaMed is forming a search committee to replace Rozynski, who joined AdvaMed in 1989...

You may also be interested in...



International News In Brief

Marjory Searing: AdvaMed names former Clinton administration trade advisor VP-global strategy & analysis. Currently senior-VP at Civic Service, Inc., a Japan-focused consulting firm, Searing begins Dec. 2 at AdvaMed, where she succeeds Ed Rozynski (1"The Gray Sheet" April 19, 2002, In Brief). With 27 years of experience at the Treasury Department and Department of Commerce, including a post as deputy assistant secretary for Asia, Searing has worked on the market-oriented, sector-selective (MOSS) agreements to improve market access for medical products in Japan...

Cosmetic And Personal Care Trademark Review: 16 April

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Health And Wellness Weekly Trademarks Review: 16 April

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT017021

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel